Glial fibrillary acidic protein
Biomarker6 papers1 findingMeSH D005904
- Human trial2
- Humans3
Interventions
1Marine omega-3 fatty acids
downin humans1Moderate certainty
1 study
Marine omega-3 fatty acids
downin humans1Moderate certainty
Marine omega-3 fatty acids decrease glial fibrillary acidic protein in humans (-12.4% (95% CI: -21.5% to -2.2%)).
Human trialin Black participantsplasma1 g/day4 years
Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial · Alzheimer's & dementia (New York, N. Y.) · 14 Sep 2026
Latest
87The Journal of Prevention of Alzheimer's DiseaseHuman trial
Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications
Frontiers in NeuroscienceAnimals
Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease
Alzheimer's & DementiaHumans
Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome
Alzheimer's & DementiaHumans